Skip to Main Content

Paper Details

Author Correction: Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants.
Nat Med
0
2024
CRISPR, SARS-, SARS-CoV-2
Author NameAffiliation
Daniel J ParkBroad Institute of MIT and Harvard
Andrew E RosenbergMassachusetts General Hospital
Andrew E RosenbergMassachusetts General Hospital and Harvard Medical School
Pardis C SabetiBroad Institute of MIT and Harvard
Pardis C SabetiHoward Hughes Medical Institute
Pardis C SabetiKoch Institute for Integrative Cancer Research at Massachusetts Institute of Technology
Pardis C SabetiHarvard T.H. Chan School of Public Health, Harvard University
Pardis C SabetiHarvard University
Pardis C SabetiBroad Institute of MIT and Harvard
Pardis C SabetiHarvard University
Pardis C SabetiHarvard T.H. Chan School of Public Health, Harvard University
Pardis C SabetiKoch Institute for Integrative Cancer Research at Massachusetts Institute of Technology
Pardis C SabetiHoward Hughes Medical Institute
Cameron MyhrvoldPrinceton University
  • 1 - 14

Datasets

Release 1.2